Late-onset <em>NPM1</em> mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib Not … ← Cross-sectional associations of self-perceived stress and hair cortisol with metabolic outcomes and microvascular complications in type 2 diabetes Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency →